Nanthealth Stock Target Price and Analyst Consensus

NH
 Stock
  

USD 0.57  0.01  1.79%   

The current analyst and expert consensus on Nanthealth is Strong Buy, with 0 strong sell and 2 strong buy opinions. The current projected Nanthealth target price consensus is 3.25 with 2 analyst opinions. The most common way Nanthealth analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Nanthealth executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Nanthealth. We encourage you to use your own analysis of Nanthealth to validate this buy or sell advice. Nanthealth buy-or-sell recommendation module provides average expert sentiment on the projected Nanthealth target price to derive its highest and lowest estimates based on projected price volatility of 1.06. Additionally, see Macroaxis Advice on Nanthealth to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
The current Gross Profit is estimated to decrease to about 47.2 M. Nanthealth Total Assets are most likely to increase significantly in the upcoming years. The last year's value of Total Assets was reported at 329.29 Million. The current Current Assets is estimated to increase to about 46.6 M, while Receivables is projected to decrease to roughly 12 M.

Nanthealth Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nanthealth target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Nanthealth target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions2
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Nanthealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nanthealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nanthealth, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Nanthealth Target Price Projection

Nanthealth's current and average target prices are 0.57 and 3.25, respectively. The current price of Nanthealth is the price at which Nanthealth is currently trading. On the other hand, Nanthealth's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Nanthealth Market Quote on 11th of August 2022

Low Price0.55Odds
High Price0.57Odds

0.57

Target Price

Analyst Consensus On Nanthealth Target Price

Low Estimate2.5Odds
High Estimate4.0Odds
Number of Analysts2
Standard Deviation1.06

3.25

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Nanthealth and the information provided on this page.

Nanthealth Analyst Ratings

Nanthealth's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Nanthealth stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Nanthealth's financials, market performance, and future outlook by experienced professionals. Nanthealth's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Nanthealth Target Price Projections

Nanthealth's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Nanthealth and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Nanthealth depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Nanthealth including analysis of its current option contracts.
Nanthealth's latest option contracts expiring on 2022-08-19 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-08-19. The current put volume is at 0, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio. The Nanthealth option chain provides detailed quote and price information for the current Nanthealth option contracts. It shows all of Nanthealth's listed puts, calls, expiration dates, strike prices, and other pricing information.
Nanthealth's stock options are financial instruments that give investors the right to buy or sell shares of Nanthealth common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Nanthealth stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Nanthealth's stock price goes up or down, the stock options follow.
Additionally, see Macroaxis Advice on Nanthealth to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Nanthealth Current Options Market Mood

Nanthealth's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Nanthealth Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most options investors, including buyers and sellers of Nanthealth's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Nanthealth's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Nanthealth's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Nanthealth Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Nanthealth is a key component of Nanthealth valuation and have some predictive power on the future returns of a Nanthealth.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Nanthealth's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Nanthealth in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.566.12
Details
Intrinsic
Valuation
LowReal ValueHigh
0.061.216.77
Details
Naive
Forecast
LowNext ValueHigh
0.0101330.516.06
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-0.4-0.39-0.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nanthealth. Your research has to be compared to or analyzed against Nanthealth's peers to derive any actionable benefits. When done correctly, Nanthealth's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Nanthealth.

Additional Nanthealth Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Nanthealth is a key component of Nanthealth valuation and have some predictive power on the future returns of a Nanthealth.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Nanthealth's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Nanthealth in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.566.12
Details
Intrinsic
Valuation
LowReal ValueHigh
0.061.216.77
Details
Naive
Forecast
LowNext ValueHigh
0.0101330.516.06
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-0.4-0.39-0.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nanthealth. Your research has to be compared to or analyzed against Nanthealth's peers to derive any actionable benefits. When done correctly, Nanthealth's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Nanthealth.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested one share
Additionally, see Macroaxis Advice on Nanthealth to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The data published in Nanthealth's official financial statements usually reflect Nanthealth's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nanthealth. For example, before you start analyzing numbers published by Nanthealth accountants, it's critical to develop an understanding of what Nanthealth's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Nanthealth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nanthealth's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nanthealth's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nanthealth. Please utilize our Beneish M Score to check the likelihood of Nanthealth's management to manipulate its earnings.